Premium
Reversible cutaneous lymphoma occurring during methotrexate therapy
Author(s) -
VIRABEN R.,
BROUSSE P.,
LAMANT L.
Publication year - 1996
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1046/j.1365-2133.1996.d01-946.x
Subject(s) - methotrexate , medicine , lymphoma , rheumatoid arthritis , virus , epstein–barr virus , antibody , pathology , hepatitis , cutaneous lymphoma , carcinoma , immunology , mycosis fungoides
Summary A B‐cell lymphoma, restricted to the skin, developed in a 58‐year‐old man receiving methotrexate for non‐rheumatoid peripheral arthritis, with the simultaneous occurrence of a cytolytic hepatitis and carcinoma of the lung. Two weeks after methotrexate was stopped, both the skin tumour and the hepatitis disappeared spontaneously, with no recurrence during a 12‐month follow‐up period. Immunoglobulin gene rearrangement was shown by polymerase chain reaction (PCR) but in situ hybridization failed to reveal neoplastic cells positive for Epstein‐Barr virus (EBV).